title: Quality of life in patients receiving high-dose interferon alfa-2b after resected high-risk melanoma.
authors.forename: Peter
authors.initials: P
authors.lastname: Mohr
authors.forename: Axel
authors.initials: A
authors.lastname: Hauschild
authors.forename: Uwe
authors.initials: U
authors.lastname: Trefzer
authors.forename: Michael
authors.initials: M
authors.lastname: Weichenthal
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008545:Melanoma / Q000188:drug therapy* / Q000523:psychology* / Q000601:surgery; D011788:Quality of Life; D011994:Recombinant Proteins; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000523:psychology* / Q000601:surgery
chemical_list: D000970:Antineoplastic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins